BRIEF-AstraZeneca Says Symbicort Approved In China For Mild Asthma
26 Jan 2021 / 15:19 H.
Jan 26 (Reuters) - AstraZeneca PLC:
* ASTRAZENECA PLC - SYMBICORT APPROVED IN CHINA FOR MILD ASTHMA
* ASTRAZENECA - SYMBICORT TURBUHALER BECOMES FIRST DUAL-COMBINATION THERAPY APPROVED IN CHINA FOR MILD, MODERATE AND SEVERE ASTHMA Source text for Eikon: Further company coverage:
Did you like this article?
